Researchers from Regenstrief Institute and Indiana University including Alexia Torke, M.D., (left) and Amber Comer, PhD, J.D. (right), report in a study published in JAMA Network Open that nearly half of the time medical treatments and orders received for incapacitated patients were not compatible with goals of care requested by their surrogate decision makers. Credit: Regenstrief Institute

Researchers from Regenstrief Institute and Indiana University report that nearly half of the time medical treatments and orders received for incapacitated patients were not compatible with goals of care requested by their surrogate decision makers. The most common disagreement involved a "full-code" medical order prepared for patients whose surrogates had indicated preference for less aggressive care options.

"The significant lack of agreement that we found between the surrogate's wishes on behalf of an incapacitated patient and the care that is actually being provided is concerning and that concern is heightened during the pandemic, as many COVID-19 cannot make decisions for themselves because they are on ventilators and sedated," said Regenstrief Institute Research Scientist Alexia Torke, M.D., associate professor of medicine at IU School of Medicine and the senior author of the new study which is published on JAMA Network Open. "Family members and other can't visit patients during the pandemic, which also means they can't gather information and feedback from the nurses, doctors and other clinicians, making two-way communication with the care team more difficult than ever."

In the study, which was carried out at three hospitals, surrogates of patients age 65 and older were asked to classify treatment they wished the patient to have into one of three categories—comfort care (focused primarily on relief of pain and suffering), intermediate care (routine hospital care such as oxygen and intravenous medications) or aggressive care ("full code" including cardio-pulmonary resuscitation, ventilator and other therapies available in an ICU). The surrogate's preferred goal of care was compared with electronic medical record (EMR) data outlining treatment received and medical orders written during the patient's hospitalization. The surrogate's preferred goal of care did not agree with the EMR data 47 percent of the time.

"How can we decrease discordance between what the surrogate wants and what actually happens in the hospital? We need to start at the beginning, before the patient loses capacity to engage in advance care planning, thus ensuring the patient and surrogate are on the same page," said Dr. Torke, who has conducted several previous studies on surrogate making. "Then good communication—preferably face to face—between the surrogate and clinicians during hospitalization is important to ensure the patient receives the care they and the surrogate desire.

"This is not TV or the movies—only one in eight critically ill patients will survive CPR. Difficult decisions have to be made and they can best be made when the surrogate knows the patient's wishes and has successful two-way communication with the care team," she observed.

The researchers found that patients who resided in a nursing home were more likely to receive medical care that agreed with the surrogate's stated goals of care than individuals who were admitted to the hospital directly from their own home. Individuals who lived with their surrogates or saw them at least weekly were more likely to receive the care that the surrogate requested than patients who had less contact with the surrogate.

"No matter how well you think you know someone, there is no substitute for having a conversation about his or her end-of-life wishes," said study co-author Amber R. Comer, Ph.D., J.D., of IU School of Health and Human Sciences at IUPUI, the study's corresponding author. "These conversations are crucial for ensuring that loved one receives that he or she would have wanted. These conversations help alleviate some of the stress that surrogates experience when trying to make these difficult life and death decisions." Dr. Comer is a Regenstrief Institute affiliated scientist.

More information: Amber R. Comer et al. Assessment of Discordance Between Surrogate Care Goals and Medical Treatment Provided to Older Adults With Serious Illness, JAMA Network Open (2020). DOI: 10.1001/jamanetworkopen.2020.5179

Journal information: JAMA Network Open